🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The present clinical study aims to verify the effectiveness and safety of t...
Status
Completed
Location
IRCCS Don Carlo Gnocchi
Start Date
2021-12-01
Trial ID
NCT05130814
Dydrogesterone is approved in more than 100 countries including Russia, Ukr...
Status
Completed
Location
Site reference ID/Investiagor# 82286
Start Date
2012-08
Trial ID
NCT01711216
PROACTIVE NYS is a long-term follow-up study of all infants who test positi...
Status
Recruiting
Location
Stony Brook Children's Hospital
Start Date
2024-02-01
Trial ID
NCT06226558
Cisplatin and Etoposide is the standard of care in NEC originating from the...
Status
Unknown
Location
S.C. Oncologia - Policlinico
Start Date
2015-05
Trial ID
NCT02687958
Treatments Being Tested
This is a study to evaluate safety and effectiveness of Ilaris in adult and...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2025-03-29
Trial ID
NCT06838143
Treatments Being Tested
International Observational Registry on Schizophrenia...
Status
Completed
Location
Multiple Locations
Start Date
2009-06
Trial ID
NCT01026285
Treatments Being Tested
The goal of this observational study is to increase the understanding of th...
Status
Recruiting
Location
MedStar Washington Hospital Center
Start Date
2025-07-28
Trial ID
NCT06422871
Treatments Being Tested
To evaluate the long-term safety of RGL-193 capsid injection in patients wi...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-15
Trial ID
NCT07279844
Treatments Being Tested
This observational study will examine the association of chronic traumatic ...
Status
Recruiting
Location
Walter Reed National Military Medical Center
Start Date
2023-11-27
Trial ID
NCT06034509
Treatments Being Tested
To identify predictive factors of adalimumab (anti TNF) response in patient...
Status
Completed
Location
Beaujon Hospital
Start Date
2013-04
Trial ID
NCT02856763